Management of Acute Cholecystitis in Cancer Patients: a Comparative Effectiveness Approach

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2014 Apr 2

PMID 24687416

Citations 3

Authors

Thejus T Jayakrishnan

Ryan T Groeschl

Ben George

James P Thomas

Sam Pappas

T Clark Gamblin

Kiran K Turaga

Affiliations

Soon will be listed here.

Abstract

Background: Host factors and therapy characteristics predispose cancer patients to a high risk of acute cholecystitis. Management of cholecystitis is often difficult given complex decision making involving the underlying cancer, possible interruption of treatment, and surgical fitness of the patient.

Methods: A management pathway was developed for cholecystitis in cancer patients which incorporated patient-specific survival and risks of recurrence. Estimates were obtained from a multistage systematic review. A decision tree with a lifetime horizon was constructed to compare conventional strategies [conservative treatment (CT), percutaneous cholecystostomy (PC) and definitive cholecystectomy (DC)] with the new pathway (NP). The decision tree was optimized for highest estimated survival. Sensitivity analyses were performed.

Results: In low surgical risk patients with cancer-specific survival of 12 months, the NP yielded estimated survivals of 11.9 versus 11.8 (CT) versus 11.8 (PC) versus 11.9 months for the DC arm. For high-risk patients, the estimated survival was 11.6 (NP), 9.9 (DC), 11.4 (PC), and 11 (CT) months, respectively. The decision to perform a DC at 6 weeks after a PC was optimum in patients expected to survive 24 months (23.2 months from the NP) or with a shorter expected survival but a high recurrence risk (>20 %). Model estimates were robust in sensitivity analyses.

Conclusions: Incorporation of the surgical risk and the risk of recurrent cholecystitis, while balancing the patient-specific survival and the impact of antineoplastic therapy in the management of cholecystitis yields improved survival. This work provides measures to evaluate surgical judgment, and can augment the physician-patient decision making.

Citing Articles

Severe complications in the induction phase of therapy in a pediatric patient with T-cell acute lymphoblastic leukemia: A case report.

Rocka A, Wozniak M, Lejman M, Zawitkowska J Medicine (Baltimore). 2023; 102(36):e34965.

PMID: 37682188 PMC: 10489477. DOI: 10.1097/MD.0000000000034965.

Case series of cancer patients who developed cholecystitis related to immune checkpoint inhibitor treatment.

Abu-Sbeih H, Tran C, Ge P, Bhutani M, Alasadi M, Naing A J Immunother Cancer. 2019; 7(1):118.

PMID: 31053161 PMC: 6499962. DOI: 10.1186/s40425-019-0604-2.

Acute Acalculous Cholecystitis in Hospitalized Patients With Hematologic Malignancies and Prognostic Importance of Gallbladder Ultrasound Findings.

Thampy R, Khan A, Zaki I, Wei W, Rao Korivi B, Staerkel G J Ultrasound Med. 2018; 38(1):51-61.

PMID: 29708270 PMC: 6207468. DOI: 10.1002/jum.14660.

References

Bakkaloglu H, Yanar H, Guloglu R, Taviloglu K, Tunca F, Aksoy M . Ultrasound guided percutaneous cholecystostomy in high-risk patients for surgical intervention. World J Gastroenterol. 2006; 12(44):7179-82. PMC: 4087782. DOI: 10.3748/wjg.v12.i44.7179. View

Kurian A, Sigal B, Plevritis S . Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol. 2009; 28(2):222-31. PMC: 2815712. DOI: 10.1200/JCO.2009.22.7991. View

Winbladh A, Gullstrand P, Svanvik J, Sandstrom P . Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford). 2009; 11(3):183-93. PMC: 2697889. DOI: 10.1111/j.1477-2574.2009.00052.x. View

Lau H, Lo C, Patil N, Yuen W . Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: a metaanalysis. Surg Endosc. 2005; 20(1):82-7. DOI: 10.1007/s00464-005-0100-2. View

Griniatsos J, Petrou A, Pappas P, Revenas K, Karavokyros I, Michail O . Percutaneous cholecystostomy without interval cholecystectomy as definitive treatment of acute cholecystitis in elderly and critically ill patients. South Med J. 2008; 101(6):586-90. DOI: 10.1097/SMJ.0b013e3181757b77. View

Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson B . Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg. 2009; 97(2):141-50. DOI: 10.1002/bjs.6870. View

Khan Z, Huth J, Kapur P, Huerta S . Indications and recommended approach for surgical intervention of metastatic disease to the gallbladder. World J Surg Oncol. 2010; 8:80. PMC: 2944133. DOI: 10.1186/1477-7819-8-80. View

Isayama H, Kawabe T, Nakai Y, Tsujino T, Sasahira N, Yamamoto N . Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006; 4(9):1148-53. DOI: 10.1016/j.cgh.2006.06.004. View

Bennett G, Balthazar E . Ultrasound and CT evaluation of emergent gallbladder pathology. Radiol Clin North Am. 2003; 41(6):1203-16. DOI: 10.1016/s0033-8389(03)00097-6. View

10.

van Overhagen H, Meyers H, Tilanus H, Jeekel J, Lameris J . Percutaneous cholecystectomy for patients with acute cholecystitis and an increased surgical risk. Cardiovasc Intervent Radiol. 1996; 19(2):72-6. DOI: 10.1007/BF02563896. View

11.

Chung Y, Choi E, Kim K, Kim M, Lee J, Lee K . Can percutaneous cholecystostomy be a definitive management for acute acalculous cholecystitis?. J Clin Gastroenterol. 2011; 46(3):216-9. DOI: 10.1097/MCG.0b013e3182274375. View

12.

Rodriguez-Sanjuan J, Arruabarrena A, Sanchez-Moreno L, Gonzalez-Sanchez F, Herrera L, Gomez-Fleitas M . Acute cholecystitis in high surgical risk patients: percutaneous cholecystostomy or emergency cholecystectomy?. Am J Surg. 2011; 204(1):54-9. DOI: 10.1016/j.amjsurg.2011.05.013. View

13.

Ercan M, Birol Bostanci E, Ulas M, Ozer I, Ozogul Y, Seven C . Effects of previous abdominal surgery incision type on complications and conversion rate in laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech. 2009; 19(5):373-8. DOI: 10.1097/SLE.0b013e3181b92935. View

14.

Bicher A, Sahin A, Burke T . Metastatic cervical cancer presenting as cholecystitis. Gynecol Oncol. 1994; 54(2):250-3. DOI: 10.1006/gyno.1994.1203. View

15.

Norlen O, Hessman O, Stalberg P, Akerstrom G, Hellman P . Prophylactic cholecystectomy in midgut carcinoid patients. World J Surg. 2010; 34(6):1361-7. DOI: 10.1007/s00268-010-0428-1. View

16.

Gutknecht D . Metastatic lung cancer presenting as cholecystitis. Am J Gastroenterol. 1998; 93(10):1986-9. DOI: 10.1111/j.1572-0241.1998.00563.x. View

17.

Blankenberg F, Wirth R, Jeffrey Jr R, Mindelzun R, Francis I . Computed tomography as an adjunct to ultrasound in the diagnosis of acute acalculous cholecystitis. Gastrointest Radiol. 1991; 16(2):149-53. DOI: 10.1007/BF01887331. View

18.

Aihara Y, Yoshiji H, Yamazaki M, Ikenaka Y, Noguchi R, Morioka C . A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma. World J Gastrointest Oncol. 2012; 4(5):115-8. PMC: 3360105. DOI: 10.4251/wjgo.v4.i5.115. View

19.

Yokoe M, Takada T, Strasberg S, Solomkin J, Mayumi T, Gomi H . New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012; 19(5):578-85. PMC: 3429769. DOI: 10.1007/s00534-012-0548-0. View

20.

Chok K, Chu F, Cheung T, Lam V, Yuen W, Ng K . Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis. ANZ J Surg. 2010; 80(4):280-3. DOI: 10.1111/j.1445-2197.2009.05105.x. View